Swiss National Bank
ZOM

Swiss National Bank’s Zomedica Corp. ZOM Stock Holding History

Swiss National Bank’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,201,200
Closed -$742K – 2851
2022
Q1 		$742K Buy
2,201,200
+156,100
+8% +$51.1K ﹤0.01% 2505
2021
Q4 		$627K Hold
2,045,100
– – ﹤0.01% 2614
2021
Q3 		$1.07M Buy
2,045,100
+61,400
+3% +$36.2K ﹤0.01% 2408
2021
Q2 		$1.65M Buy
+1,983,700
New +$1.85M ﹤0.01% 2227

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
PWMG
Pinnacle Wealth Management Group Plymouth, Michigan $214M AUM 20.07% 1-Year Est. Return

Swiss National Bank's ZOM Position: Q2 2022 in Review

Swiss National Bank sold out of Zomedica Corp. (ZOM) in Q2 2022, closing a stake of 2,201,200 shares — an estimated $742K sold.

Swiss National Bank first reported a position in ZOM in Q2 2021 and held it in 4 quarters. The position peaked at $1.65M in Q2 2021. 97 funds tracked by Wall St. Rank hold ZOM as of Q2 2022.

  • Swiss National Bank reported no remaining Zomedica Corp. position as of Q2 2022 after selling out during the quarter.
  • Swiss National Bank sold 2,201,200 Zomedica Corp. shares in Q2 2022, an estimated $742K.
  • Swiss National Bank first reported a position in Zomedica Corp. in Q2 2021 and held it in 4 quarters.
  • Swiss National Bank's Zomedica Corp. position peaked at $1.65M in Q2 2021.
  • 97 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2022.

Based on Swiss National Bank's 13F filing for Q2 2022, filed 9 Aug 2022.